Abstract
Transforming growth factor beta (TGFβ) regulates cell adhesion, proliferation, and differentiation in a variety of cells. Smad proteins are receptor-activated transcription factors that translocate to the nucleus in response to TGFβ. We demonstrate here that TGFβ increases cell adhesion in metastatic PC3-M prostate cancer cells. TGFβ treatment of PC3-M cells leads to nuclear translocation of R-Smad proteins. We show that Smad proteins are necessary, but not sufficient, for TGFβ-mediated cell adhesion. After showing that TGFβ upregulated p38 MAP kinase activity in PC3-M cells, we show that inhibition of p38 MAP kinase partially blocked TGFβ-mediated increase in cell adhesion, as well as nuclear translocation of Smad3. Finally, we show that Smad3 is phosphorylated by p38 MAP kinase in vitro. These findings implicate crosstalk between the MAP kinase and Smad signaling pathways in TGFβ's regulation of cell adhesion in human prostate cells. This represents a mechanism by which the pleiotropic effects of TGFβ may be channeled to modulate cell adhesion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arteaga CL, Coffey Jr RJ, Dugger TC, McCutchen CM, Moses HL and Lyons RM . (1990). Cell Growth Differ., 1, 367–374.
Attisano L and Wrana JL . (2002). Science, 296, 1646–1647.
Bakin AV, Rinehart C, Tomlinson AK and Arteaga CL . (2002). J. Cell Sci., 115, 3193–3206.
Bergan R, Hakim F, Schwartz GN, Kyle E, Cepada R, Szabo JM, Fowler D, Gress R and Neckers L . (1996a). Blood, 88, 731–741.
Bergan R, Kyle E, Nguyen P, Trepel J, Ingui C and Neckers L . (1996b). Clin. Exp. Metastasis, 14, 389–398.
Bissell DM, Roulot D and George J . (2001). Hepatology, 34, 859–867.
Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L and Dubois CM . (2001). J. Biol. Chem., 276, 33986–33994.
Brodin G, ten Dijke P, Funa K, Heldin CH and Landstrom M . (1999). Cancer Res., 59, 2731–2738.
Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y and Wang XF . (1999). Mol. Cell. Biol., 19, 2495–2504.
Dennler S, Goumans MJ and ten Dijke P . (2002). J. Leukoc. Biol., 71, 731–740.
Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ and Davis RJ . (1995). Science, 267, 682–685.
Derynck R and Feng XH . (1997). Biochim. Biophys. Acta, 1333, F105–F150.
Dong C, Li Z, Alvarez R, Jr Feng XH and Goldschmidt-Clermont PJ . (2000). Mol. Cell, 5, 27–34.
Fantz DA, Jacobs D, Glossip D and Kornfeld K . (2001). J. Biol. Chem., 276, 27256–27265.
Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D and Teti A . (1999). Int. J. Cancer, 81, 395–403.
Galanis A, Yang SH and Sharrocks AD . (2001). J. Biol. Chem., 276, 965–973.
Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K and Nishida E . (1999). J. Biol. Chem., 274, 27161–27167.
Hayashida T, Poncelet AC, Hubchak SC and Schnaper HW . (1999). Kidney Int., 56, 1710–1720.
Heldin CH, Miyazono K and ten Dijke P . (1997). Nature, 390, 465–471.
Hsing AY, Kadomatsu K, Bonham MJ and Danielpour D . (1996). Cancer Res., 56, 5146–5149.
Hu PP, Shen X, Huang D, Liu Y, Counter C and Wang XF . (1999). J. Biol. Chem., 274, 35381–35387.
Ignotz RA and Massague J . (1986). J. Biol. Chem., 261, 4337–4345.
Ignotz RA and Massague J . (1987). Cell, 51, 189–197.
Karsdal MA, Fjording MS, Foged NT, Delaisse JM and Lochter A . (2001). J. Biol. Chem., 276, 39350–39358.
Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM and Lee C . (1998). Clin. Cancer Res., 4, 1625–1630.
Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM and Lee C . (1996a). Clin. Cancer Res., 2, 1255–1261.
Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M and Lee C . (1996b). Cancer Res., 56, 44–48.
Kostenuik PJ, Singh G and Orr FW . (1997). Clin. Exp. Metastasis, 15, 41–52.
Kovarik P, Stoiber D, Eyers PA, Menghini R, Neininger A, Gaestel M, Cohen P and Decker T . (1999). Proc. Natl. Acad. Sci. USA, 96, 13956–13961.
Kozlowski JM, Isaiah JF, Campbell D, Xu ZL, Kaighn ME and Hart IR . (1984). Cancer Res., 44, 3522–3529.
Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC and Young PR . (1997). Biochem. Biophys. Res. Commun., 235, 533–538.
Kyle E, Neckers L, Takimoto C, Curt G and Bergan R . (1997). Mol. Pharmacol., 51, 193–200.
Kyriakis JM and Avruch J . (2001). Physiol. Rev., 81, 807–869.
Laiho M and Keski-Oja J . (1992). Crit. Rev. Oncogene, 3, 1–26.
Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P and Heldin CH . (2000). Curr. Biol., 10, 535–538.
Latil A, Pesche S, Valeri A, Fournier G, Cussenot O and Lidereau R . (1999). Prostate, 40, 225–231.
Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA and Lodish HF . (1997). Proc. Nat. Acad. Sci. USA, 94, 10669–10674.
Liu Y, Kyle E, Lieberman R, Crowell J, Kellof G and Bergan RC . (2000). Clin. Exp. Metastasis, 18, 203–212.
Liu Y, Kyle E, Patel S, Housseau F, Harkim F, Lieberman R, Pins M, Blogosklonny M and Bergan R . (2001). Pros. Cancer Pros. Dis., 4, 81–91.
Liu YQ, Jovanovic B, Pins M, Lee C and Bergan RC . (2002). Oncogene, 21, 8272–8281.
Lucia MS, Sporn MB, Roberts AB, Stewart LV and Danielpour D . (1998). J. Cell Physiol., 175, 184–192.
Massague J . (2000). Nat. Rev. Mol. Cell Biol., 1, 169–178.
Massague J and Wotton D . (2000). EMBO J., 19, 1745–1754.
Miyazono K, ten Dijke P and Heldin CH . (2000). Adv. Immunol., 75, 115–157.
Mooradian DL, Purchio AF and Furcht LT . (1990). Cancer Res., 50, 273–277.
Moustakas A, Souchelnytskyi S and Heldin CH . (2001). J. Cell Sci., 114, 4359–4369.
Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K and ten Dijke P . (1997). EMBO J., 16, 5353–5362.
Olsson N, Piek E, Sundstrom M, ten Dijke P and Nilsson G . (2001). Cell Signal, 13, 483–490.
Ozen M and Pathak S . (2000). Anticancer Res., 20, 1905–1912.
Paine E, Palmantier R, Akiyama SK, Olden K and Roberts JD . (2000). J. Biol. Chem., 275, 11284–11290.
Paul R, Ewing CM, Jarrard DF and Isaacs WB . (1997). Br. J. Urol., 79 (Suppl 1), 37–43.
Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP and Roberts AB . (2001). J. Biol. Chem., 276, 19945–19953.
Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J and Kahari VM . (1999). J. Biol. Chem., 274, 37292–37300.
Roberts AB . (1998). Miner. Electrolyte Metab., 24, 111–119.
Rohlff C, Blagosklonny MV, Kyle E, Kesari A, Kim IY, Zelner DJ, Hakim F, Trepel J and Bergan RC . (1998). Prostate, 37, 51–59.
Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T and Ishii S . (1999). J. Biol. Chem., 274, 8949–8957.
Schnaper HW . (1998). Pediatr. Nephrol., 12, 790–795.
Sehgal I, Baley PA and Thompson TC . (1996). Cancer Res., 56, 3359–3365.
Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML and Pargellis CA . (1997). Nat. Struct. Biol., 4, 311–316.
Ungefroren H, Lenschow W, Chen WB, Faendrich F and Kalthoff H . (2003). J. Biol. Chem., 278, 11041–11049.
Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A and Platanias LC . (2001). J. Biol. Chem., 31, 31.
Wagers AJ and Kansas GS . (2000). J. Immunol., 165, 5011–5016.
Wakefield LM and Roberts AB . (2002). Curr. Opin. Genet. Dev., 12, 22–29.
Wang L, Ma R, Flavell RA and Choi ME . (2002). J. Biol. Chem., 277, 47257–47262.
Welch DR, Fabra A and Nakajima M . (1990). Proc. Natl. Acad. Sci USA, 87, 7678–7682.
Wilding G, Zugmeier G, Knabbe C, Flanders K and Gelmann E . (1989). Mol. Cell. Endocrinol., 62, 79–87.
Wilson KP, McCaffrey PO, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA and Su MS . (1997). Chem. Biol., 4, 423–431.
Xiao BG, Zhang GX, Ma CG and Link H . (1996). Clin. Exp. Immunol., 103, 475–481.
Yamamoto T, Kozawa O, Tanabe K, Akamatsu S, Matsuno H, Dohi S and Uematsu T . (2001). J. Cell Biochem., 82, 591–598.
Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR and Guise TA . (1999). J. Clin. Invest., 103, 197–206.
Yu L, Hebert MC and Zhang YE . (2002). EMBO J., 21, 3749–3759.
Zhang Y, Feng XH and Derynck R . (1998). Nature, 394, 909–913.
Acknowledgements
This work was supported by a Prostate SPORE grant from the National Cancer Institute (CA90386) and by grants CA77816 and CA9407 (to LCP). SAH is a Drug Discovery Program Postdoctoral Scholar (T32 AG00260).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayes, S., Huang, X., Kambhampati, S. et al. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Oncogene 22, 4841–4850 (2003). https://doi.org/10.1038/sj.onc.1206730
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206730
Keywords
This article is cited by
-
MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression
Journal of Experimental & Clinical Cancer Research (2019)
-
Hemodynamic shear stress induces protective autophagy in HeLa cells through lipid raft-mediated mechanotransduction
Clinical & Experimental Metastasis (2018)
-
Expression of inflammatory and fibrogenetic markers in acne hypertrophic scar formation: focusing on role of TGF-β and IGF-1R
Archives of Dermatological Research (2018)
-
TGF-β regulates phosphorylation and stabilization of Sox9 protein in chondrocytes through p38 and Smad dependent mechanisms
Scientific Reports (2016)
-
Inhibition of cancer cell invasion and metastasis by genistein
Cancer and Metastasis Reviews (2010)